Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 388

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection

Open access
Anderson, Elizabeth M., Goodwin, Eileen C., Verma, Anurag, Arevalo, Claudia P., Bolton, Marcus J., Weirick, Madison E., Gouma, Sigrid, McAllister, Christopher M., Christensen, Shannon R., Weaver, JoEllen, Hicks, Philip, Manzoni, Tomaz B., Oniyide, Oluwatosin, Ramage, Holly, Mathew, Divij, Baxter, Amy E., Oldridge, Derek A., Greenplate, Allison R., Wu, Jennifer E., Alanio, Cécile, D’Andrea, Kurt, Kuthuru, Oliva, Dougherty, Jeanette, Pattekar, Ajinkya, Kim, Justin, Han, Nicholas, Apostolidis, Sokratis A., Huang, Alex C., Vella, Laura A., Kuri-Cervantes, Leticia, Pampena, M. Betina, Betts, Michael R., Wherry, E. John, Meyer, Nuala J., Cherry, Sara, Bates, Paul, Rader, Daniel J., Hensley, Scott E.·2021·Cell

Published version of a preprint

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread within the human population. Although SARS-CoV-2 is a novel coronavirus, most humans had been previously exposed to other antigenically distinct common seasonal human coronaviruses (hCoVs) before the coronavirus disease 2019 (COVID-19) pandemic. Here, we quantified levels of SARS-CoV-2-reactive antibodies and hCoV-reactive antibodies in serum samples collected from 431 humans before the COVID-19 pandemic. We then quantified pre-pandemic antibody levels in serum from a separate cohort of 251 individuals who became PCR-confirmed infected with SARS-CoV-2. Finally, we longitudinally measured hCoV and SARS-CoV-2 antibodies in the serum of hospitalized COVID-19 patients. Our studies indicate that most individuals possessed hCoV-reactive antibodies before the COVID-19 pandemic. We determined that ∼20% of these individuals possessed non-neutralizing antibodies that cross-reacted with SARS-CoV-2 spike and nucleocapsid proteins. These antibodies were not associated with protection against SARS-CoV-2 infections or hospitalizations, but they were boosted upon SARS-CoV-2 infection.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cell.2021.02.010

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 2

  1. Anderson, 2020, SARS-CoV-2 antibody responses in children with MIS-C and mild and severe COVID-19, J. Pediatric Infect. Dis. Soc., piaa161
  2. Poston, 2020, Absence of SARS-CoV-2 neutralizing activity in pre-pandemic sera from individuals with recent seasonal coronavirus infection, Clin. Infect. Dis., ciaa1803

Cited by

See all 388

Metadata

Authors
Anderson, E. M., Goodwin, E. C., Verma, A., Arevalo, C. P., Bolton, M. J., Weirick, M. E., Gouma, S., McAllister, C. M., Christensen, S. R., Weaver, J., Hicks, P., Manzoni, T. B., Oniyide, O., Ramage, H., Mathew, D., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., D’Andrea, K., Kuthuru, O., Dougherty, J., Pattekar, A., Kim, J., Han, N., Apostolidis, S. A., Huang, A. C., Vella, L. A., Kuri-Cervantes, L., Pampena, M. B., Betts, M. R., Wherry, E. J., Meyer, N. J., Cherry, S., Bates, P., Rader, D. J., & Hensley, S. E.
Venue
Cell
Publisher
Elsevier BV
Published
2021-04
Volume
184
Issue
7
Pages
1858-1864.e10
ISSN
0092-8674 (ISSN-L)
OpenAlex
W3126847903
Cited by
388
References
32
FWCI
25.17
Type
journal article
Language
en
Open access
bronze
Funders
  • NIH
  • US Department of Defense

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. https://app.cochat.ai/papers/10.1016/j.cell.2021.02.010
The paper
Anderson, E. M., Goodwin, E. C., Verma, A., Arevalo, C. P., Bolton, M. J., Weirick, M. E., Gouma, S., McAllister, C. M., Christensen, S. R., Weaver, J., Hicks, P., Manzoni, T. B., Oniyide, O., Ramage, H., Mathew, D., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., . . . Hensley, S. E. (2021). Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection. Cell. https://doi.org/10.1016/j.cell.2021.02.010

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.